Business Context and Reporting Period
This Form 8-K is a current report filed by Nukkleus Inc. (trading symbol: NUKK) on October 11, 2024. The filing details corporate actions taken following the Company's Annual Meeting of Stockholders held on the same date. The Company is an emerging growth company incorporated in Delaware and listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on capital structure changes and shareholder voting results.
Material Changes and Corporate Actions
- Reverse Stock Split: The Board approved a 1-for-8 reverse stock split. The Certificate of Amendment was filed to become effective at 12:01 a.m. Eastern Time on October 24, 2024. The primary objective is to raise the per-share bid price above $1.00 to regain compliance with Nasdaq Listing Rule 5550(a)(2).
- Authorized Share Increase: Stockholders approved an amendment to increase the number of authorized common shares from 40,000,000 to 150,000,000. This amendment was effective upon filing on October 18, 2024.
- Trading Adjustments: Common stock will begin trading on a split-adjusted basis on October 24, 2024, under the existing symbol "NUKK" with a new CUSIP number (67054R203). Exercise prices for outstanding options and warrants will be proportionately adjusted.
- Fractional Shares: Stockholders entitled to fractional shares will receive one whole share for their fractional interest.
Shareholder Voting Results
At the Annual Meeting, 9,642,977 shares were represented (out of 16,791,964 outstanding on the record date). Key voting outcomes included:
- Director Elections: Seven directors were elected. Notably, Reuven Yeganeh and Anastasiia Kotaieva received significant "withheld" votes (approximately 1.28 million and 1.27 million, respectively), while other directors received minimal withheld votes.
- Reverse Stock Split Authorization: Approved with 9,578,664 votes "For" and 61,751 "Against."
- Equity Incentive Plan: The 2024 Equity Incentive Plan authorizing 10,000,000 shares was approved with 8,635,313 votes "For."
- Authorized Share Increase: Approved with 9,509,516 votes "For."
- Auditor Ratification: GreenGrowth CPAs were ratified as the independent registered public accounting firm.
Outlook, Risks, and Contingencies
The Company states that the reverse stock split is intended to restore compliance with Nasdaq listing requirements. However, the filing includes standard forward-looking statement disclaimers, noting that there is no guarantee the Company will successfully maintain its Nasdaq listing or that the split will achieve the desired price increase. Risks include the potential failure to regain compliance and the general uncertainties associated with the reverse stock split.
Investor Verification Checklist
- Verify the effective date of the reverse stock split (October 24, 2024) and the new CUSIP number (67054R203) for trading purposes.
- Confirm the adjusted exercise prices of any held stock options or warrants following the 1-for-8 split.
- Monitor the stock price post-split to determine if the Company successfully meets the $1.00 minimum bid price requirement for Nasdaq compliance.
- Review the significant "withheld" votes for directors Reuven Yeganeh and Anastasiia Kotaieva for potential governance implications.
- Check subsequent filings for confirmation of the Company's continued listing status on Nasdaq.